Methods of international health technology assessment agencies for economic evaluations- a comparative analysis

被引:54
作者
Mathes, Tim [1 ]
Jacobs, Esther [1 ]
Morfeld, Jana-Carina [1 ]
Pieper, Dawid [1 ]
机构
[1] Univ Witten Herdecke, Fac Hlth, Sch Med, Inst Res Operat Med, D-51109 Cologne, Germany
来源
BMC HEALTH SERVICES RESEARCH | 2013年 / 13卷
关键词
COST-EFFECTIVENESS; DECISION-MAKING; ASSESSMENT ORGANIZATIONS; KEY PRINCIPLES; GUIDELINES; CARE; GENERALIZABILITY; UNCERTAINTY;
D O I
10.1186/1472-6963-13-371
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The number of Health Technology Assessment (HTA) agencies increases. One component of HTAs are economic aspects. To incorporate economic aspects commonly economic evaluations are performed. A convergence of recommendations for methods of health economic evaluations between international HTA agencies would facilitate the adaption of results to different settings and avoid unnecessary expense. A first step in this direction is a detailed analysis of existing similarities and differences in recommendations to identify potential for harmonization. The objective is to provide an overview and comparison of the methodological recommendations of international HTA agencies for economic evaluations. Methods: The webpages of 127 international HTA agencies were searched for guidelines containing recommendations on methods for the preparation of economic evaluations. Additionally, the HTA agencies were requested information on methods for economic evaluations. Recommendations of the included guidelines were extracted in standardized tables according to 13 methodological aspects. All process steps were performed independently by two reviewers. Results: Finally 25 publications of 14 HTA agencies were included in the analysis. Methods for economic evaluations vary widely. The greatest accordance could be found for the type of analysis and comparator. Cost-utility-analyses or cost-effectiveness-analyses are recommended. The comparator should continuously be usual care. Again the greatest differences were shown in the recommendations on the measurement/sources of effects, discounting and in the analysis of sensitivity. The main difference regarding effects is the focus either on efficacy or effectiveness. Recommended discounting rates range from 1.5% - 5% for effects and 3% - 5% for costs whereby it is mostly recommended to use the same rate for costs and effects. With respect to the analysis of sensitivity the main difference is that oftentimes the probabilistic or deterministic approach is recommended exclusively. Methods for modeling are only described vaguely and mainly with the rational that the "appropriate model" depends on the decision problem. Considering all other aspects a comparison is challenging as recommendations vary regarding detailedness and addressed issues. Conclusion: There is a considerable unexplainable variance in recommendations. Further effort is needed to harmonize methods for preparing economic evaluations.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Quality Decision Making in Health Technology Assessment: Issues Facing Companies and Agencies
    Magdalena Bujar
    Neil McAuslane
    Stuart R. Walker
    Sam Salek
    [J]. Therapeutic Innovation & Regulatory Science, 2020, 54 : 275 - 282
  • [32] Portfolio frontier analysis: Applying mean-variance analysis to health technology assessment for health systems under pressure
    Baines, Darrin
    Disegna, Marta
    Hartwell, Christopher A.
    [J]. SOCIAL SCIENCE & MEDICINE, 2021, 276
  • [33] The economics of health information technology in medication management: a systematic review of economic evaluations
    O'Reilly, Daria
    Tarride, Jean-Eric
    Goeree, Ron
    Lokker, Cynthia
    McKibbon, K. Ann
    [J]. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2012, 19 (03) : 423 - 438
  • [34] Quality Decision Making in Health Technology Assessment: Issues Facing Companies and Agencies
    Bujar, Magdalena
    McAuslane, Neil
    Walker, Stuart R.
    Salek, Sam
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (02) : 275 - 282
  • [35] Methods for the health technology assessment of complex interventions: a protocol for a scoping review
    Baghbanian, Abdolvahab
    Merlin, Tracy
    Carter, Drew
    Wang, Shuhong
    [J]. BMJ OPEN, 2020, 10 (11):
  • [36] Modes of coordination for health technology adoption: Health Technology Assessment agencies and Group Procurement Organizations in a polycentric regulatory regime
    Miller, Fiona A.
    Lehoux, Pascale
    Rac, Valeria E.
    Bytautas, Jessica P.
    Krahn, Murray
    Peacock, Stuart
    [J]. SOCIAL SCIENCE & MEDICINE, 2020, 265
  • [37] A SWOT analysis of the development of health technology assessment in Iran
    Behzadifar, Masoud
    Ghanbari, Mahboubeh Khaton
    Azari, Samad
    Bakhtiari, Ahad
    Rahimi, Sara
    Ehsanzadeh, Seyed Jafar
    Sharafkhani, Naser
    Moridi, Salman
    Bragazzi, Nicola Luigi
    [J]. PLOS ONE, 2023, 18 (03):
  • [38] Multiple Criteria Decision Analysis for Health Technology Assessment
    Thokala, Praueen
    Duenas, Alejandra
    [J]. VALUE IN HEALTH, 2012, 15 (08) : 1172 - 1181
  • [39] Trial-Based Economic Evaluations in Occupational Health Principles, Methods, and Recommendations
    van Dongen, Johanna M.
    van Wier, Marieke F.
    Tompa, Emile
    Bongers, Paulien M.
    van der Beek, Allard J.
    van Tulder, Maurits W.
    Bosmans, Judith E.
    [J]. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2014, 56 (06) : 563 - 572
  • [40] Health Technology Assessment and Economic Evaluation across Jurisdictions
    Simoens, Steven
    [J]. VALUE IN HEALTH, 2010, 13 (06) : 857 - 859